View Older Stories View More Recent Stories
-
TD Cowen Reiterates Buy Rating on Boston Scientific (BSX)
-
Boston Scientific (BSX) PT Raised to $98 at RBC Capital
-
CL King Reiterates Buy Rating on Boston Scientific (BSX)
-
Buy the dip in this MedTech stock says Citi
-
Boston Scientific (BSX) Tops Q3 EPS by 4c; offers guidance
-
Boston Scientific (BSX) call put ratio 1.7 calls to 1 put into quarter results
-
Boston Scientific (BSX) call put ratio 2 calls to 1 put into quarter results
-
Boston Scientific (BSX) PT Raised to $100 at TD Cowen
-
Piper Sandler Reiterates Overweight Rating on Boston Scientific (BSX)
-
Boston Scientific (BSX) PT Raised to $98 at Canaccord Genuity
-
Boston Scientific (BSX) Launches Next Generation of Cardiac Mapping for the FARAPULSE⢠Pulsed Field Ablation System
-
Boston Scientific (BSX) PT Raised to $100 at Stifel
-
Boston Scientific (BSX) PT Raised to $100 at Baird
-
TD Cowen Reiterates Buy Rating on Boston Scientific (BSX)
-
TD Cowen Reiterates Buy Rating on Boston Scientific (BSX)
-
Boston Scientific (BSX) Receives Japanese Regulatory Approval for the FARAPULSE Pulsed Field Ablation System
-
BofA Securities Reiterates Buy Rating on Boston Scientific (BSX)
-
Piper Sandler Reiterates Overweight Rating on Boston Scientific (BSX)
-
Boston Scientific (BSX) Closes Acquisition of Silk Road Medical
-
Boston Scientific (BSX) Receives FDA Approval for Expanded Indication of INGEVITY+ Pacing Leads
-
Boston Scientific (BSX) Appoints David Habiger to its Board
-
Boston Scientific (BSX) PT Raised to $91 at Baird
-
Boston Scientific (BSX) PT Raised to $88 at Canaccord Genuity
-
Boston Scientific (BSX) PT Raised to $78 at Deutsche Bank
-
Boston Scientific (BSX) PT Raised to $90 at Jefferies
-
BTIG Reiterates Buy Rating on Boston Scientific (BSX)
-
Boston Scientific (BSX) PT Raised to $82 at Evercore ISI
-
Midday movers: Tesla, Alphabet, Visa fall; AT&T, Texas Instruments rise
-
Citi Reiterates Buy Rating on Boston Scientific (BSX), Top Pick
-
Boston Scientific (BSX) Tops Q2 EPS by 4c; offers guidance
-
Boston Scientific (BSX) call put ratio 1.3 calls to 1 put into quarter results
-
Boston Scientific (BSX) call put ratio 11.5 calls to 1 put with focus on August 85 calls
-
This MedTech stock surge could surge after earnings says TD Cowen
-
Boston Scientific (BSX) PT Raised to $86 at TD Cowen
-
Boston Scientific (BSX) PT Raised to $90 at Truist Securities
-
Boston Scientific (BSX) PT Raised to $100 at Mizuho
-
MedTech stocks: Q2 earnings season preview
-
Silk Road Medical to be acquired by Boston Scientific, shares surge 24%
-
Canaccord Genuity Boston Scientific (BSX) at Buy following Silk Road Medical (SILK) deal
-
Boston Scientific (BSX) to Acquire Silk Road Medical (SILK) for $27.50/sh or $1.16B
-
Boston Scientific (BSX) PT Raised to $90 at Baird
-
3 MedTech stocks to own - Citi
-
3 MedTech stocks to own for 2024
-
Wall Street ticks higher, but chip stocks tumble

